Recombinant human interleukin-2 became available for clinical use
in the mid 1980s. Recent years have seen an enormous amount of
clinical research with this cytokine and interleukin-2 has now been
registered for use in a number of European countries for the
treatment of metastatic renal cell carcinoma. This book is designed
to provide the clinical oncologist wishing to use interleukin-2
with a basic background concerning the biology of the agent, a
discussion concerning practical aspects, of its clinical use
including management of toxicity and an overview of the clinical
results together with a description of how this interesting
cytokine might be developed in the future.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!